Semax

Semax is a seven-residue peptide combining an ACTH fragment with a proline-glycine-proline C-terminal extension. It is manufactured predominantly in eastern Europe, and documentation standards vary more widely than for peptides made under US or western European quality systems.

We treat the completeness of the analytical package as a qualification criterion in this line rather than a negotiating point, because incomplete certificates are the norm rather than the exception.

Typical related substances are truncated ACTH fragments, oxidised methionine variants and residual acetate.

Not an approved drug substance in the United States and not on the 503A bulks list.